MCL1 (Myeloid cell leukemia 1), another potential target of GA (Figure S6, Supporting Information), which can protect cancer cells especially TNBC from apoptosis and decrease their sensitivity to anticancer therapies.[23] Similar to TRX protein, MCL1 showed tight associations with numerous ferroptosis‐related genes (Figure S4, Supporting Information). Here, TXN is linked to cancer.